Priority for pSivida's Iluvien; Patent, job, Tweet, and Video of the week;

>  The FDA has granted priority review status for Iluvien, a sustained drug delivery system to treat diabetic macular edema. Iluvien was designed by Watertown, MA-based pSivida and licensed to Alimera Sciences based in Alpharetta, GA. Report

>  The Institute of Nanotechnology and Cranfield University in the United Kingdom will present a one-day short course, "Nanotechnology for drug delivery," in association with Pharmidex, on Sept. 30. Event

>  Using carbon nanotubes to delivery siRNA. Abstract

>  Coming attractions from the FDA: New guidance and consensus standards on nanotechnology as part of its 2011 Nanotechnology Regulatory Science Initiative. Bulletin

>  A transdermal patch for delivery of contraceptives is among the offerings in India's first patent tech auction. Report

Drug delivery patent of the week: Targeted drug delivery of pain and addiction therapies using opioid receptor-mediated internalization. Patent

Drug delivery job of the week: Dry Powder Inhaler Formulator--3M Drug Delivery Systems Division, Maplewood, MN. Listing

Drug delivery Tweet of the week: @juhayy I think I died a little inside after a short lecture on intraocular way of drug delivery. Five ways of sticking a needle in the eyeball: oh my. Tweet

And Finally... CNN discovers the flu patch. Video

Suggested Articles

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.

Bexson Biomedical and Stevanato Group teamed up to develop a ketamine pump that may help patients better manage pain at home.

Australia's University of New South Wales and Uka Tarsadia University in India will join forces to explore contact lenses for ocular drug delivery.